These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 11084040
41. Regulation of the pp72syk protein tyrosine kinase by platelet integrin alpha IIb beta 3. Gao J, Zoller KE, Ginsberg MH, Brugge JS, Shattil SJ. EMBO J; 1997 Nov 03; 16(21):6414-25. PubMed ID: 9351824 [Abstract] [Full Text] [Related]
42. Inhibition of platelet integrin alpha(IIb)beta(3) by peptides that interfere with protein kinases and the beta(3) tail. Hers I, Donath J, Litjens PE, van Willigen G, Akkerman JW. Arterioscler Thromb Vasc Biol; 2000 Jun 03; 20(6):1651-60. PubMed ID: 10845885 [Abstract] [Full Text] [Related]
43. cAMP does not inhibit convulxin-induced tyrosyl-phosphorylation of human platelet proteins, including PLCgamma2, but completely blocks the integrin alphaIIb beta3-dependent dephosphorylation step: comparisons with RGDS peptide, cytochalasin D, and phenylarsine oxide. Francischetti IM, Carlini CR, Guimarães JA. Arch Biochem Biophys; 1998 Jun 15; 354(2):255-62. PubMed ID: 9637734 [Abstract] [Full Text] [Related]
44. Streptococcus sanguis-induced platelet activation involves two waves of tyrosine phosphorylation mediated by FcgammaRIIA and alphaIIbbeta3. Pampolina C, McNicol A. Thromb Haemost; 2005 May 15; 93(5):932-9. PubMed ID: 15886812 [Abstract] [Full Text] [Related]
45. RGT, a synthetic peptide corresponding to the integrin beta 3 cytoplasmic C-terminal sequence, selectively inhibits outside-in signaling in human platelets by disrupting the interaction of integrin alpha IIb beta 3 with Src kinase. Su X, Mi J, Yan J, Flevaris P, Lu Y, Liu H, Ruan Z, Wang X, Kieffer N, Chen S, Du X, Xi X. Blood; 2008 Aug 01; 112(3):592-602. PubMed ID: 18398066 [Abstract] [Full Text] [Related]
46. Tyrosine phosphorylation and relocation of SHIP are integrin-mediated in thrombin-stimulated human blood platelets. Giuriato S, Payrastre B, Drayer AL, Plantavid M, Woscholski R, Parker P, Erneux C, Chap H. J Biol Chem; 1997 Oct 24; 272(43):26857-63. PubMed ID: 9341117 [Abstract] [Full Text] [Related]
47. Ultrastructure of the interaction between human platelets and polymerizing fibrin within the first minutes of clot formation. Morgenstern E, Ruf A, Patscheke H. Blood Coagul Fibrinolysis; 1990 Oct 24; 1(4-5):543-6. PubMed ID: 2133232 [Abstract] [Full Text] [Related]
48. Inhibition of platelet-mediated clot retraction by integrin antagonists. Hantgan RR, Mousa SA. Thromb Res; 1998 Mar 15; 89(6):271-9. PubMed ID: 9669749 [Abstract] [Full Text] [Related]
49. ClfA(221-550), a fibrinogen-binding segment of Staphylococcus aureus clumping factor A, disrupts fibrinogen function. Liu CZ, Shih MH, Tsai PJ. Thromb Haemost; 2005 Aug 15; 94(2):286-94. PubMed ID: 16113817 [Abstract] [Full Text] [Related]
50. The heptapeptide LSARLAF mediates platelet activation through phospholipase Cgamma2 independently of glycoprotein IIb-IIIa. Pearce AC, Wonerow P, Marshall SJ, Frampton J, Gartner TK, Watson SP. Biochem J; 2004 Feb 15; 378(Pt 1):193-9. PubMed ID: 14558887 [Abstract] [Full Text] [Related]
51. Coordinate interactions of Csk, Src, and Syk kinases with [alpha]IIb[beta]3 initiate integrin signaling to the cytoskeleton. Obergfell A, Eto K, Mocsai A, Buensuceso C, Moores SL, Brugge JS, Lowell CA, Shattil SJ. J Cell Biol; 2002 Apr 15; 157(2):265-75. PubMed ID: 11940607 [Abstract] [Full Text] [Related]
52. Impaired platelet aggregation and sustained bleeding in mice lacking the fibrinogen motif bound by integrin alpha IIb beta 3. Holmbäck K, Danton MJ, Suh TT, Daugherty CC, Degen JL. EMBO J; 1996 Nov 01; 15(21):5760-71. PubMed ID: 8918453 [Abstract] [Full Text] [Related]
53. Glycoprotein IIb-IIIa and the translocation of Rap2B to the platelet cytoskeleton. Torti M, Ramaschi G, Sinigaglia F, Lapetina EG, Balduini C. Proc Natl Acad Sci U S A; 1994 May 10; 91(10):4239-43. PubMed ID: 8183895 [Abstract] [Full Text] [Related]
54. What is vinculin needed for in platelets? Mitsios JV, Prevost N, Kasirer-Friede A, Gutierrez E, Groisman A, Abrams CS, Wang Y, Litvinov RI, Zemljic-Harpf A, Ross RS, Shattil SJ. J Thromb Haemost; 2010 Oct 10; 8(10):2294-304. PubMed ID: 20670372 [Abstract] [Full Text] [Related]
55. The platelet cytoskeleton regulates the affinity of the integrin alpha(IIb)beta(3) for fibrinogen. Bennett JS, Zigmond S, Vilaire G, Cunningham ME, Bednar B. J Biol Chem; 1999 Sep 03; 274(36):25301-7. PubMed ID: 10464255 [Abstract] [Full Text] [Related]
56. Capture by chemical crosslinkers provides evidence that integrin alpha IIb beta 3 forms a complex with protein tyrosine kinases in intact platelets. Dorahy DJ, Berndt MC, Burns GF. Biochem J; 1995 Jul 15; 309 ( Pt 2)(Pt 2):481-90. PubMed ID: 7542870 [Abstract] [Full Text] [Related]
57. Protein tyrosine phosphatase SHP-1 fails to associate with cytoskeleton but is normally phosphorylated upon thrombin stimulation of thrombasthenic platelets. Li RY, Gaits F, Ragab-Thomas JM, Maclouf J, Caen JP, Lévy-Toledano S, Chap H. Thromb Haemost; 1997 Jan 15; 77(1):150-4. PubMed ID: 9031466 [Abstract] [Full Text] [Related]
58. Regulation of outside-in signaling in platelets by integrin-associated protein kinase C beta. Buensuceso CS, Obergfell A, Soriani A, Eto K, Kiosses WB, Arias-Salgado EG, Kawakami T, Shattil SJ. J Biol Chem; 2005 Jan 07; 280(1):644-53. PubMed ID: 15536078 [Abstract] [Full Text] [Related]
59. Selective association of the tyrosine kinases Src, Fyn, and Lyn with integrin-rich actin cytoskeletons of activated, nonaggregated platelets. Bertagnolli ME, Hudson LA, Stetsenko GY. Biochem Biophys Res Commun; 1999 Jul 14; 260(3):790-8. PubMed ID: 10403844 [Abstract] [Full Text] [Related]
60. Integrin-dependent interaction of lipid rafts with the actin cytoskeleton in activated human platelets. Bodin S, Soulet C, Tronchère H, Sié P, Gachet C, Plantavid M, Payrastre B. J Cell Sci; 2005 Feb 15; 118(Pt 4):759-69. PubMed ID: 15671066 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]